• 07 3847 7133Call us for more details!
  • LocationSuite 318, 121 Newdegate St Greenslopes, Australia
Prof Andrew Barbour Brisbane Specialist Surgery

Doctor Trial Results – Our study has shown that tailoring therapy for oesophageal cancer is feasible and merits further study.

Background: Patients with oesophageal/gastro-oesophageal junction adenocarcinoma (EAC) not showing early metabolic response (EMR) to chemotherapy have poorer survival and histological response rates <5%. We investigated whether tailoring neoadjuvant therapy can improve outcomes in these patients. Patients and methods: Patients with resectable EAC were …

Read More
13th International Gastric Cancer Congress - IGCC 2019

13th International Gastric Cancer Congress

Invited presentation at the International Gastric Cancer Congress, Prague 2019. I was asked to discuss the use of PET scans as a predictor or treatment benefit in cancer of the stomach and oesophagus based on our experience with the DOCTOR trial.

Read More